MedPath

CHLORZOXAZONE

CHLORZOXAZONE- Chlorzoxazone Tablet USP

Approved
Approval ID

fbd65956-3cbd-4bb4-b340-93ee86da6f8a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 2, 2023

Manufacturers
FDA

Belcher Pharmaceuticals LLC

DUNS: 965082543

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CHLORZOXAZONE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62250-710
Application NumberANDA215540
Product Classification
M
Marketing Category
C73584
G
Generic Name
CHLORZOXAZONE
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 2, 2023
FDA Product Classification

INGREDIENTS (8)

CHLORZOXAZONEActive
Quantity: 250 mg in 1 1
Code: H0DE420U8G
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
DOCUSATE SODIUM/SODIUM BENZOATEInactive
Code: 656HXR6YXN
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHLORZOXAZONE - FDA Drug Approval Details